Abstract:Abstract Introduction: Eight molecules that are structurally similar to angiopoietin but do not bind to angiopoietin's specific receptor Tie2 were identified and named angiopoietin-like factors (ANGPTL). ANGPTL2, particularly abundantly expressed in adipose tissue, promotes damage repair through tissue remodeling, and contributes to tissue homeostasis; however, in severe obesity, ANGPTL2 is overexpressed, resulting in irreversible tissue remodeling, which induces chronic inflammation and is involved in systemic insulin resistance and diabetes development. On the other hand, it is unclear how systemic chronic inflammation controlled by ANGPTL2 is involved in cancer progression and acquisition of immune checkpoint inhibitor (ICI) resistance. Therefore, we aimed to elucidate the mechanisms in the acquisition of ICI resistance by systemic chronic inflammation from the perspective of ANGPTL2. Materials and Methods: 1. To induce chronic inflammation in adipose tissue, BALB/c mice were fed high-fat-diet (HFD) for 6 weeks. CT26 cells, a mouse colon cancer cell line, were subcutaneously implanted in normal diet (ND) and HFD mice and anti PD-1/PD-L1 antibody was administered intraperitoneally. Immune cell fractions in tumor tissue and bone marrow were analyzed by flow cytometry. 2. CT26 was subcutaneously implanted in WT and systemic ANGPTL2-deficient (Angptl2−/−) mice, and anti PD-1/PD-L1 antibody was administered intraperitoneally. Tumor size and survival time were analyzed. Bone marrow cells were isolated and the immune cell fractions were analyzed by flow cytometry, and the expression of inflammatory cytokines in adipose tissue were also analyzed. 3. Bone marrow cells were isolated from BALB/c mice, and myeloid-derived suppressor cells (MDSCs) were established in vitro by GM-CSF and IL-6. Recombinant ANGPTL2 protein was added, and MDSC differentiation and function were evaluated by flow cytometry and qRT-PCR. Results: 1. HFD mice had larger tumor size and poorer response to ICI treatment compared to ND mice. In tumor microenvironment, MDSCs were increased in HFD mice. HFD mice had significantly increased MDSCs, especially polymorphonuclear MDSCs (PMN-MDSCs) in bone marrow. 2. ICI-treated Angptl2−/− mice showed higher treatment efficacy and prolonged survival compared to WT mice. In bone marrow, MDSCs were reduced in Angptl2−/− mice under ICI treatment. In adipose tissue, the expression of chronic inflammatory markers was increased. 3. In vitro, addition of recombinant ANGPTL2 protein to MDSCs induced differentiation from mouse bone marrow cells did not significantly increase the cell ratio of MDSCs. No changes in the expression of MDSCs markers were observed in qRT-PCR. Conclusions: Chronic inflammation induced by ANGPTL2 promotes MDSCs differentiation and maturation in the bone marrow, which may suppress anti-tumor immunity and contribute to ICI resistance. Citation Format: Shinsei Yumoto, Haruki Horiguchi, Hideo Baba, Yuichi Oike. Elucidation of the mechanism of acquisition of immune checkpoint inhibitor resistance by chronic inflammation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 7519.

Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis

Heme Oxygenase-1 in Macrophages Impairs the Perfusion Recovery after Hindlimb Ischemia by Suppressing Autolysosome-Dependent Degradation of NLRP3.

Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo

Effects of Interleukin-4 (IL-4)-releasing microparticles and adoptive transfer of macrophages on immunomodulation and angiogenesis

Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma

[CD137 signaling promotes angiogenesis through regulating macrophage M1/M2 polarization]

Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β−NF-κB/IRF3 and JAK2/TYK2−STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization

Abstract 19281: Chemokine-Coupled β2 Integrin-Dependent mRNA Stabilization in Macrophages Modulates VEGF-A Protein Levels During Ischemia-Induced Arteriogenesis

Host-derived Interleukin 1α induces an immunosuppressive tumor microenvironment via regulating monocyte-to-macrophage differentiation

Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway

Reciprocal Interaction Between Macrophages and T Cells Stimulates IFN-γ and MCP-1 Production in Ang II-induced Cardiac Inflammation and Fibrosis

p38 in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1

IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis

GRK2 Mediated Abnormal Transduction of PGE2-EP4-cAMP-CREB Signaling Induces the Imbalance of Macrophages Polarization in Collagen-Induced Arthritis Mice

The Influence of Chronic Inflammation on Angiogenesis in Mouse Malignant Melanoma

Abstract 7519: Elucidation of the mechanism of acquisition of immune checkpoint inhibitor resistance by chronic inflammation

The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages

Inflammatory M1-like macrophages polarized by NK-4 undergo enhanced phenotypic switching to an anti-inflammatory M2-like phenotype upon co-culture with apoptotic cells

Activated α(2) macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines

miR-221-3p Drives the Shift of M2-Macrophages to a Pro-Inflammatory Function by Suppressing JAK3/STAT3 Activation

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis